Establishment of a predictive model of death within 30 days for patients with liver cirrhosis and bacterial ascites
-
摘要: 目的探讨肝硬化合并细菌性腹水患者30 d内死亡的危险因素,并建立可以预测其30 d内死亡的预测模型。方法回顾性收集2012年1月-2018年4月首都医科大学附属北京地坛医院收治的肝硬化合并细菌性腹水患者86例,对其进行为期30 d的随访观察,根据患者预后将其分为生存组(n=73例)与死亡组(n=13例)。符合正态分布的计量资料组间比较采用t检验,非正态分布的计量资料组间比较采用Mann-Whitney U检验,计数资料组间比较采用χ2检验。采用logistic回归分析探讨肝硬化合并细菌性腹水患者30 d内死亡的影响因素,并根据影响因素建立预测模型。用受试者工作特征曲线下面积(AUC)评估各独立影响因素和预测模型的预测价值。结果 logistic多因素回归分析发现腹水白蛋白[比值比(OR)=0. 615,95%可信区间(95%CI):0. 424~0. 893,P=0. 011]、中性粒细胞与淋巴细胞比值(NLR)(OR=1. 170,95%CI:1. 011~1. 354,P=0. 035)、MELD评分(OR=1. 341,95%CI:1. 111~1. 618...
-
关键词:
- 肝硬化 /
- 细菌性腹水 /
- 腹膜炎 /
- 预后 /
- Logistic模型
Abstract: Objective To investigate the risk factors for death within 30 days in patients with liver cirrhosis and bacterial ascites,and to establish a predictive model of death within 30 days. Methods A retrospective analysis was performed for the clinical data of 86 patients with liver cirrhosis and bacterial ascites who were admitted to Beijing Ditan Hospital,Capital Medical University,from January 2012 to April 2018.The patients were followed up for 30 days,and according to their prognosis,they were divided into survival group with 73 patients and death group with 13 patients. The t-test was used for comparison of normally distributed continuous data between groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups. A logistic regression analysis was used to investigate the influencing factors for death within 30 days in patients with liver cirrhosis and bacterial ascites,and a predictive model was established based on these influencing factors. The area under the receiver operating characteristic curve was used to evaluate the predictive value of each independent influencing factor and the predictive model. Results The multivariate logistic regression analysis showed that there were significant differences between the survival group and the death group in ascites albumin( odds ratio [OR]= 0. 615,95% confidence interval [CI]: 0. 424-0. 893,P = 0. 011),neutrophil-to-lymphocyte ratio( NLR)( OR =1. 170,95% CI: 1. 011-1. 354,P = 0. 035),and Model for End-Stage Liver Disease( MELD) score( OR = 1. 341,95%CI: 1. 111-1. 618,P = 0. 002). A scoring model was established based on the results of the multivariate analysis to predict death within 30 days in patients with liver cirrhosis and bacterial ascites,and based on this model,the patients were divided into high-risk group with death within 30 days( score ≥2 points) and low-risk group with death within 30 days( score < 2 points). There was a significant difference in mortality rate with 30 days between the two groups( 60. 0% vs 5. 6%,P < 0. 001). Conclusion Ascites albumin ≤3. 5 g/L,NLR ≥6. 5,and MELD score ≥20 are independent risk factors for death within 30 days in patients with liver cirrhosis and bacterial ascites. The predictive model established on this basis can effectively evaluate the population at high risk of death within 30 days.-
Key words:
- liver cirrhosis /
- bacterial ascites /
- peritonitis /
- prognosis /
- logistic models
-
[1] European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis[J]. J Hepatol,2010,53(3):397-417. [2] TANDON P,KUMAR D,SEO YS,et al. The 22/11 risk prediction model:A validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis[J]. Am J Gastroenterol,2013,108(9):1473-1479. [3] ANGELONI S,LEBOFFE C,PARENTE A,et al. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice[J]. World J Gastroenterol,2008,14(17):2757-2762. [4] RUNYON BA,AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis:An update[J]. Hepatology,2009,49(6):2087-2107. [5] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol,2017,33(10):1847-1863.(in Chinese)中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志,2017,33(10):1847-1863. [6] CHEN HZ. Practical internal medicine[M]. Beijing:People’s Medical Publishing House,2001:1850.(in Chinese)陈灏珠.实用内科学[M].北京:人民卫生出版社,2001:1850. [7] ILIAZ R,OZPOLAT T,BARAN B,et al. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers[J]. Eur J Gastroenterol Hepatol,2018,30(7):786-791. [8] OLIVEIRA AM,BRANCO JC,BAROSA R,et al. Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis:A multicenter cohort study[J]. Eur J Gastroenterol Hepatol,2016,28(10):1216-1222. [9] HEO J,SEO YS,YIM HJ,et al. Clinical features and prognosis of spontaneous bacterial peritonitis in Korean patients with liver cirrhosis:A multicenter retrospective study[J]. Gut Liver,2009,3(3):197-204. [10] NOBRE SR,CABRAL JE,GOMES JJ,et al. In-hospital mortality in spontaneous bacterial peritonitis:A new predictive model[J]. Eur J Gastroenterol Hepatol,2008,20(12):1176-1181. [11] XIONG Q,ZHOU YF,YANG GW. Changes and significance of serum and ascites CA125 and albumin levels in patients with cirrhosis and spontaneous bacterial peritonitis[J]. Shandong Med J,2016,56(13):43-44.(in Chinese)熊琴,周英发,杨国威.肝硬化并自发性细菌性腹膜炎患者血清和腹水中CA125、白蛋白水平变化及意义[J].山东医药,2016,56(13):43-44. [12] FERNANDEZ J,NAVASA M,GARCIA-PAGAN JC,et al.Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis[J]. J Hepatol,2004,41(3):384-390. [13] FAN Y,LI X,ZHOU XF,et al. Value of neutrophil-lymphocyte ratio in predicting hepatitis B-related liver failure[J]. Chin J Hepatol,2017,25(10):726-731.(in Chinese)范玥,李欣,周晓芳,等.中性粒细胞淋巴细胞比值在预测乙型肝炎相关肝衰竭中的作用[J].中华肝脏病杂志,2017,25(10):726-731. [14] FERNANDEZ-RUIZ M,LOPEZ-MEDRANO F,ROMO EM,et al. Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation[J].Liver Transpl,2009,15(10):1209-1216. [15] GUARNER C,SORIANO G. Bacterial translocation and its consequences in patients with cirrhosis[J]. Eur J Gastroenterol Hepatol,2005,17(1):27-31. [16] LI LJ,WU ZW. Study on the role of intestinal microecological changes in chronic liver diseases[J]. Chin J Microecol,2002,14(2):2-3.(in Chinese)李兰娟,吴仲文.重视肠道微生态变化在慢性肝病中作用的研究[J].中国微生态学杂志,2002,14(2):2-3. [17] GUO YN,XU YQ,WANG L. Study on the relationship between procalcitonin in ascites,cytokines and intestinal mucosal barrier function in patients with cirrhosis and spontaneous peritonitis[J]. J Clin Exp Med,2019,18(14):1528-1531.(in Chinese)郭玉宁,徐有青,王麟.肝硬化合并自发性细菌性腹膜炎患者腹水降钙素原与细胞因子和肠黏膜屏障功能的相关性研究[J].临床和实验医学杂志,2019,18(14):1528-1531. [18] LIU JQ. Understanding the structural shifts of gut microbiota in patients with chronic viral hepatitis B[D]. Shanghai:Shanghai Jiao Tong University,2011.(in Chinese)刘嘉颀.慢性乙型肝炎患者肠道菌群结构的分子生态学研究[D].上海:上海交通大学,2011. [19] TONG XB. Clinical analysis of 90 cases of cirrhotic ascites with spontaneous bacterial peritonitis[J]. Int Med China,2015,10(5):672-673.(in Chinese)童锡宝.肝硬化腹水伴自发性细菌性腹膜炎90例临床分析[J].内科,2015,10(5):672-673. [20] YI AF. Essentials of hepatitis B cirrhosis complicated with spontaneous bacterial peritonitis[J]. J Qiqihar Med Coll,2014,35(6):844-845.(in Chinese)易爱芬.乙肝肝硬化并发自发性细菌性腹膜炎关键要点探索[J].齐齐哈尔医学院学报,2014,35(6):844-845. [21] WEI CJ,LI DH,WANG CM. Corynebacterium urealyticum-an important pathogen of clinical opportunistic infections[J]. Int J Lab Med,2017,38(1):89-91.(in Chinese)魏超君,李德红,王超美.解脲棒杆菌———重要的临床机会性感染病原菌[J].国际检验医学杂志,2017,38(1):89-91. 期刊类型引用(17)
1. 郭堑,农村立,韦秋芳. 慢性乙型肝炎肝纤维化患者血清Copeptin和PCT表达水平及其临床价值研究. 现代检验医学杂志. 2023(02): 112-117+189 . 百度学术
2. 李初谊,王俊科,李斌,温雪,魏晓静,于晓辉. 血浆置换对慢加急性肝衰竭辅助治疗的效果评价. 海南医学院学报. 2022(16): 1228-1231 . 百度学术
3. 王鑫,张国民,牛兴杰,李萍,张冰. 外周血CD14~+CD16~+单核细胞亚群在肝衰竭继发感染患者中的检测价值. 中国免疫学杂志. 2020(09): 1124-1127+1130 . 百度学术
4. 姜曼蕾,许飞,胡江玲,罗嘉裕,罗方云. IL-6、CRP、PCT和内毒素预判肝衰竭合并细菌感染风险中的临床价值. 中华医院感染学杂志. 2020(20): 3062-3065 . 百度学术
5. 张国民,王鑫,韩智炜,牛兴杰,刘志慧,崔凤梅. 降钙素原、白细胞介素6、sCD14、CD64检测在肝功能衰竭患者诊治中的临床研究. 中国现代医学杂志. 2019(03): 47-51 . 百度学术
6. 江艳霞,骆小燕,骆旭航,龚安安,孙爱华. 血清降钙素原在胆管炎危重度早期评估中的价值研究. 中国卫生检验杂志. 2019(04): 462-463+468 . 百度学术
7. 张国民,韩智炜,牛兴杰,刘志慧,王鑫. IL-6、CD14、CD64检测在感染所致肝衰竭患者中意义. 现代医学. 2019(02): 137-140 . 百度学术
8. 黄波,张炜. 喜炎平注射液联合还原型谷胱甘肽治疗重症烧伤后急性肝功能损伤临床研究. 创伤与急危重病医学. 2019(03): 156-159 . 百度学术
9. 杨丽霞,张伦理,赖玲玲,方铭. 腹水中肝素结合蛋白及降钙素原对肝硬化腹水伴自发性细菌性腹膜炎的诊断价值. 临床肝胆病杂志. 2019(06): 1266-1269 . 本站查看
10. 李薇,任小丹,何谦,周荣幸. 血清降钙素原检测对胆道梗阻合并感染者的预测价值. 中华实验和临床感染病杂志(电子版). 2019(03): 245-249 . 百度学术
11. 张国民,韩智炜,牛兴杰,刘志慧,崔凤梅,王鑫. PCT、IL-6、CD14、CD64及TNF-α表达对肝衰竭合并医院感染患者预后的影响. 中华医院感染学杂志. 2019(16): 2450-2453 . 百度学术
12. 王鑫,张国民,牛兴杰,李萍,张冰. 肝衰竭继发感染患者外周血Toll样受体4及降钙素原、C反应蛋白变化情况分析. 现代消化及介入诊疗. 2019(10): 1084-1087+1094 . 百度学术
13. 石春霞,陈倩,王瑶,焦方舟,龚作炯. 肝功能衰竭并感染患者血清正五聚蛋白3和肝素结合蛋白及降钙素原水平变化. 中华实用诊断与治疗杂志. 2019(12): 1188-1190 . 百度学术
14. 顾静,王艳,陈丽,徐英,甘建和. HBV相关慢加急性肝衰竭患者血清IL-32和IL-10水平变化及意义. 临床肝胆病杂志. 2018(04): 801-805 . 本站查看
15. 王小芳,奉万盛,周红翠,邱咏佳. 血清降钙素原、白细胞计数、C-反应蛋白与细菌血培养联合检测在感染患者中的应用价值. 中国医药导报. 2018(19): 75-78 . 百度学术
16. 沈素晶,邓超,李霭文,谭俊青. 不同化学发光检测系统测定PCT结果的相关性分析. 实验与检验医学. 2018(06): 873-875+891 . 百度学术
17. 詹金美,林欢,孙家敏. 定量检测血清降钙素原在诊断肝衰竭患者腹腔感染细菌类型中的价值. 中外医疗. 2017(28): 34-36 . 百度学术
其他类型引用(1)
-